FDA Plans Workshop to Discuss Upcoming Drug Supply Chain Pilots

The Food and Drug Administration announced a public workshop April 5-6 at FDA headquarters in Silver Spring, Md. to discuss upcoming pilots required under the Drug Supply Chain Security Act. According to the agency’s notice (here), FDA is interested in getting input from drug supply chain members on “issues related to utilizing the product identifier for product tracing, improving the technical capabilities of the supply chain, and identifying the system attributes that are necessary to implement the requirements established” by the 2013 law. Requests to register are due by March 11. Written comments related to the workshop are due April 21.